Target intelligence / Profile preview

Sodium-dependent phosphate transporter 1 (PiT1) (PiT1)

Target
PiT1
Molecular classification
Transporter, Solute carrier family 20 member 1, Sodium-phosphate cotransporter, Type III sodium-dependent phosphate cotransporter
01

Overview

Sodium-dependent phosphate transporter 1, commonly known as PiT1 or SLC20A1, is a transmembrane protein that functions as a high-affinity, sodium-dependent symporter for inorganic phosphate [1, 10]. It is ubiquitously expressed and plays a vital role in maintaining cellular phosphate homeostasis, which is essential for metabolism, signal transduction, and the synthesis of nucleic acids and lipids [2, 11]. Beyond its transport function, PiT1 is involved in regulating cell proliferation, TNF-induced apoptosis, and insulin signaling [3, 5]. In clinical contexts, PiT1 is a key driver of pathological vascular calcification, particularly in patients with chronic kidney disease or diabetes, as its upregulation promotes the osteogenic transdifferentiation of vascular smooth muscle cells [6, 12, 16]. It also serves as a receptor for the gibbon ape leukemia virus and has been linked to the progression of several cancers, including breast and pituitary adenomas [2, 5]. Therapeutic strategies targeting PiT1, such as the use of the inhibitor phosphonoformic acid (foscarnet), aim to prevent cardiovascular mineralization, although systemic safety concerns regarding phosphate balance and liver function must be addressed [6, 12, 13].

Other names
SLC20A1GLVR1Glvr-1Pit-1Sodium-dependent phosphate symporter 1Gibbon ape leukemia virus receptor 1
02

Mechanism of action

Competitive inhibition of sodium-dependent inorganic phosphate transport across the plasma membrane

03

Biological functions

Phosphate homeostasisCell proliferationApoptosis regulationSignal transductionInsulin signalingRetroviral entryErythropoiesisSynaptic plasticity
04

Disease associations

Cardiovascular diseaseVascular calcificationCancerInflammationWerner syndromeCalcific aortic valve disease
05

Safety considerations

Systemic phosphate imbalance (hypophosphatemia)Potential liver toxicity and impaired hematopoiesisAnemiaDisruption of bone mineralizationPotential cognitive or neurological side effects
06

Interacting drugs

Phosphonoformic acid

1 more in the full profile.

07

Biomarkers

Serum phosphate levelsPiT1 mRNA/protein expressionRunx2 expressionOsteopontin levelsIntracellular ATP levels

Beyond the preview

Go deeper on Sodium-dependent phosphate transporter 1 (PiT1) (PiT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent phosphate transporter 1 (PiT1) (PiT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call